MAPT and Alzheimer disease: This peptide is implicated in the neuropathological hallmarks of Alzheimer’s disease (AD), which include enhanced oxidative stress [2], pronounced inflammation [3], deposition in the brain of Aβ-insoluble aggregates [4,5], and the formation of neurofibrillary tangles due to the aggregation of hyperphosphorylated tau [6].